New hope for Moms-to-Be: drug targets dangerous pregnancy itch
NCT ID NCT07389031
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a drug called maralixibat in 28 pregnant women with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching and high bile acids. The main goal is to see if the drug is safe and tolerable for both mother and baby. Researchers will also check if it helps reduce itching and lower bile acid levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLESTASIS OF PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Birmingham Womens and Childrens NHS Foundation Trust
Birmingham, B15 2TG, United Kingdom
-
Guy's and St Thomas' NHS Foundation Trust
London, SE 1 7EH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.